Antibody drug conjugates (ADCs) mark a new era in targeted cancer therapy, delivering potent cytotoxic chemotherapy via monoclonal antibodies directly into the tumor cells — an era with potentially ...
Explore how digital feedback controllers manage motors, pressure, temperature, and more, and learn why ADC and DAC performance are crucial when designing robust embedded systems. How to define the ...
While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...
AbbVie’s Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who have received prior lines of treatment. The FDA signed off on AbbVie’s ...
Forbes contributors publish independent expert analyses and insights. I track enterprise software application development & data management. Platforms dominate technology. We talk about Microsoft’s ...
Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...
Citrix Netscaler is the latest target in widespread password spray attacks targeting edge networking devices and cloud platforms this year to breach corporate networks. In March, Cisco reported that ...
ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed antibody-drug conjugate (ADC) after failing to show a favorable benefit-risk profile ...
FORT LAUDERDALE, Fla. & ATLANTA--(BUSINESS WIRE)--Citrix, a business unit of Cloud Software Group, Inc., today announced the general availability of Citrix VDA for macOS, expanding their desktop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback